In this 45-minute webinar on demand and Q&A, Willemijn Groenendaal will give an overview of imec’s solutions for continuous respiratory monitoring.
This webinar on demand is supported by SEMI
Are your working for a medical device or pharma company, or are you involved in research on respiratory diseases? Would you like to know the answer to the questions below? Then this webinar on demand will be of interest to you.
COVID-19 has put respiratory diseases high on the healthcare agenda worldwide. When the world is amid a full-swing pandemic it is obvious to see the gaps in technology and standard of care on respiratory diseases.
The current standard of care for patients suffering from respiratory diseases such as COPD and asthma is heavily hospital centric.
Respiratory patients are expected to come to the hospital for examination and physician office visits in intervals of several months with limited objective data available between visits. Physician examinations include questionnaires and obtrusive spirometer measurements requiring trained personnel.
However, disease worsening typically does not follow the schedule for hospital visits. As a result, 270-600 million of so-called COPD exacerbations happen per year, causing irreparable lung damage. COPD costs alone are estimated to be close to 100 billion per year in the EU and US combined, with most of these costs related to flares. Then COPD is only one of the multiple respiratory diseases.
What if we could change the respiratory standards of care and make remote monitoring solutions for respiratory conditions reliable, predictive and unobtrusive? And would such solutions also be applicable for disease outbreaks such as the current COVID-19 pandemic?
In this webinar on demand we will address these questions and present scientific evidence and current steps imec is taking towards improving respiratory care.
Willemijn Groenendaal is a principal scientist at imec, where she leads research activities with a focus on wearable monitoring and algorithms in the clinical domain. She is involved in studies with patients suffering from COPD (Chronic Obstructive Pulmonary Disease), sleep apnea, and heart failure. These studies are done in close collaboration with hospitals.
Willemijn Groenendaal received her master’s and Ph.D. degrees from the Eindhoven University of Technology, Eindhoven, The Netherlands, in 2006 and 2011, respectively. She has been a Postdoctoral Associate with the Weill Cornell Medical College, New York, NY, USA.